CARDIFF ONCOLOGY, INC. Unrealized Gain (Loss) on Derivatives
CARDIFF ONCOLOGY, INC. (CRDF) reported Unrealized Gain (Loss) on Derivatives of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2023-03-02
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for fiscal 2021 was $285.00K.
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for fiscal 2020 was -$281.00K, a 1096.88% decline from fiscal 2019.
- CARDIFF ONCOLOGY, INC. unrealized gain (loss) on derivatives for fiscal 2019 was $28.19K, a 95.43% decline from fiscal 2018.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 3 month as first filed | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 6 month as first filed | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 9 month as first filed | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 12 month as first filed | Unrealized Gain (Loss) on Derivatives 152 month | Unrealized Gain (Loss) on Derivatives 155 month | Unrealized Gain (Loss) on Derivatives 158 month | Unrealized Gain (Loss) on Derivatives 161 month | Unrealized Gain (Loss) on Derivatives 164 month | Unrealized Gain (Loss) on Derivatives 167 month | Unrealized Gain (Loss) on Derivatives 170 month | Unrealized Gain (Loss) on Derivatives 173 month | Unrealized Gain (Loss) on Derivatives 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | |||||||||||||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $5.00K derived: sum of 4 quarters · filed 2023-03-02 | |||||||||||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $5.00K derived: sum of 3 quarters · filed 2023-03-02 | $17.00K derived: sum of 4 quarters · filed 2023-03-02 | |||||||||||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $5.00K derived: sum of 2 quarters · filed 2023-03-02 | $17.00K derived: sum of 3 quarters · filed 2023-03-02 | $78.00K derived: sum of 4 quarters · filed 2023-03-02 | |||||||||||||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $17.00K derived: sum of 2 quarters · filed 2023-03-02 | $78.00K derived: sum of 3 quarters · filed 2023-03-02 | $285.00K 10-K · filed 2023-03-02 | |||||||||||||
| 2021-09-30 | $12.00K 10-Q · filed 2022-11-03 | $73.00K derived: sum of 2 quarters · filed 2022-11-03 | $280.00K 10-Q · filed 2022-11-03 | $185.00K derived: sum of 4 quarters · filed 2022-11-03 | |||||||||||||
| 2021-06-30 | $61.00K 10-Q · filed 2022-08-04 | $268.00K 10-Q · filed 2022-08-04 | $173.00K derived: sum of 3 quarters · filed 2022-08-04 | $29.00K derived: sum of 4 quarters · filed 2022-08-04 | |||||||||||||
| 2021-03-31 | $207.00K 10-Q · filed 2022-05-05 | $112.00K derived: sum of 2 quarters · filed 2022-05-05 | -$32.00K derived: sum of 3 quarters · filed 2022-05-05 | -$76.00K derived: sum of 4 quarters · filed 2022-05-05 | |||||||||||||
| 2020-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$239.00K derived: sum of 2 quarters · filed 2022-02-24 | -$283.00K derived: sum of 3 quarters · filed 2022-02-24 | -$281.00K 10-K · filed 2022-02-24 | -$280.84K 10-K · filed 2021-02-25 | ||||||||||||
| 2020-09-30 | -$144.00K 10-Q · filed 2021-11-04 | -$144.03K 10-Q · filed 2020-11-05 | -$188.00K derived: sum of 2 quarters · filed 2021-11-04 | -$186.00K 10-Q · filed 2021-11-04 | -$186.07K 10-Q · filed 2020-11-05 | -$185.17K derived: sum of 4 quarters · filed 2021-11-04 | |||||||||||
| 2020-06-30 | -$44.00K 10-Q · filed 2021-08-05 | -$44.14K 10-Q · filed 2020-08-11 | -$42.00K 10-Q · filed 2021-08-05 | -$42.04K 10-Q · filed 2020-08-11 | -$41.17K derived: sum of 3 quarters · filed 2021-08-05 | -$27.84K derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-06 | $2.11K 10-Q · filed 2020-05-07 | $2.83K derived: sum of 2 quarters · filed 2021-05-06 | $16.16K derived: sum of 3 quarters · filed 2021-05-06 | $39.95K derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||
| 2019-12-31 | $829.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $14.16K derived: sum of 2 quarters · filed 2021-02-25 | $37.95K derived: sum of 3 quarters · filed 2021-02-25 | $28.19K 10-K · filed 2021-02-25 | |||||||||||||
| 2019-09-30 | $13.33K 10-Q · filed 2020-11-05 | $37.12K derived: sum of 2 quarters · filed 2020-11-05 | $27.36K 10-Q · filed 2020-11-05 | $65.39K derived: sum of 4 quarters · filed 2020-11-05 | |||||||||||||
| 2019-06-30 | $23.79K 10-Q · filed 2020-08-11 | $14.03K 10-Q · filed 2020-08-11 | $52.06K derived: sum of 3 quarters · filed 2020-08-11 | $49.56K derived: sum of 4 quarters · filed 2020-08-11 | |||||||||||||
| 2019-03-31 | -$9.76K 10-Q · filed 2020-05-07 | $28.27K derived: sum of 2 quarters · filed 2020-05-07 | $25.77K derived: sum of 3 quarters · filed 2020-05-07 | $737.00K derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||||
| 2018-12-31 | $38.03K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $35.53K derived: sum of 2 quarters · filed 2020-02-27 | $746.76K derived: sum of 3 quarters · filed 2020-02-27 | $617.07K 10-K · filed 2020-02-27 | |||||||||||||
| 2018-09-30 | -$2.50K 10-Q · filed 2019-11-07 | $708.73K derived: sum of 2 quarters · filed 2019-11-07 | $579.04K 10-Q · filed 2019-11-07 | $1.97M derived: sum of 4 quarters · filed 2019-11-07 | |||||||||||||
| 2018-06-30 | $711.23K 10-Q · filed 2019-08-08 | $581.54K 10-Q · filed 2019-08-08 | $1.97M derived: sum of 3 quarters · filed 2019-08-08 | $3.50M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||||||
| 2018-03-31 | -$129.69K 10-Q · filed 2019-05-07 | $1.26M derived: sum of 2 quarters · filed 2019-05-07 | $2.79M derived: sum of 3 quarters · filed 2019-05-07 | $2.72M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2017-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $2.92M derived: sum of 2 quarters · filed 2019-03-06 | $2.85M derived: sum of 3 quarters · filed 2019-03-06 | $3.40M 10-K · filed 2019-03-06 | |||||||||||||
| 2017-09-30 | $1.53M 10-Q · filed 2018-11-07 | $1.46M derived: sum of 2 quarters · filed 2018-11-07 | $2.01M 10-Q · filed 2018-11-07 | $3.80M derived: sum of 4 quarters · filed 2018-11-07 | |||||||||||||
| 2017-06-30 | -$71.43K 10-Q · filed 2018-08-03 | $484.08K 10-Q · filed 2018-08-03 | $2.27M derived: sum of 3 quarters · filed 2018-08-03 | $2.36M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||||
| 2017-03-31 | $555.51K 10-Q · filed 2018-05-08 | $2.34M derived: sum of 2 quarters · filed 2018-05-08 | $2.43M derived: sum of 3 quarters · filed 2018-05-08 | $2.48M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||||||
| 2016-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.88M derived: sum of 2 quarters · filed 2018-02-26 | $1.93M derived: sum of 3 quarters · filed 2018-02-26 | $2.46M 10-K · filed 2018-02-26 | |||||||||||||
| 2016-09-30 | $88.21K 10-Q · filed 2017-11-09 | $141.08K derived: sum of 2 quarters · filed 2017-11-09 | $674.83K 10-Q · filed 2017-11-09 | $1.05M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||
| 2016-06-30 | $52.88K 10-Q · filed 2017-08-09 | $586.63K 10-Q · filed 2017-08-09 | $965.48K derived: sum of 3 quarters · filed 2017-08-09 | $4.98M derived: sum of 4 quarters · filed 2017-08-09 | |||||||||||||
| 2016-03-31 | $533.75K 10-Q · filed 2017-05-10 | $912.60K derived: sum of 2 quarters · filed 2017-05-10 | $4.93M derived: sum of 3 quarters · filed 2017-05-10 | $1.75M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||||
| 2015-12-31 | $378.85K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $4.40M derived: sum of 2 quarters · filed 2017-03-15 | $1.22M derived: sum of 3 quarters · filed 2017-03-15 | -$726.42K 10-K · filed 2017-03-15 | |||||||||||||
| 2015-09-30 | $4.02M 10-Q · filed 2016-11-09 | $841.46K derived: sum of 2 quarters · filed 2016-11-09 | -$1.11M 10-Q · filed 2016-11-09 | -$900.08K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-06-30 | -$3.18M 10-Q · filed 2016-08-04 | -$5.12M 10-Q · filed 2016-08-04 | -$4.92M derived: sum of 3 quarters · filed 2017-03-15 | -$5.95M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-03-31 | -$1.95M 10-Q · filed 2016-05-10 | -$1.74M derived: sum of 2 quarters · filed 2017-03-15 | -$2.77M derived: sum of 3 quarters · filed 2017-03-15 | -$553.72K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2014-12-31 | $205.19K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$824.14K derived: sum of 2 quarters · filed 2017-03-15 | $1.39M derived: sum of 3 quarters · filed 2017-03-15 | $1.43M 10-K · filed 2017-03-15 | |||||||||||||
| 2014-09-30 | -$1.03M 10-Q · filed 2015-11-09 | $1.19M derived: sum of 2 quarters · filed 2015-11-09 | $1.22M 10-Q · filed 2015-11-09 | $3.07M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||
| 2014-06-30 | $2.22M 10-Q · filed 2015-08-10 | $2.25M 10-Q · filed 2015-08-10 | $4.10M derived: sum of 3 quarters · filed 2016-03-10 | $2.78M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||
| 2014-03-31 | $32.85K 10-Q · filed 2015-05-05 | $1.88M derived: sum of 2 quarters · filed 2016-03-10 | $564.90K derived: sum of 3 quarters · filed 2016-03-10 | -$2.33M derived: sum of 4 quarters · filed 2016-03-10 | -$6.55M 10-Q · filed 2014-05-12 | ||||||||||||
| 2013-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $532.05K derived: sum of 2 quarters · filed 2016-03-10 | -$2.36M derived: sum of 3 quarters · filed 2016-03-10 | -$1.08M 10-K · filed 2016-03-10 | -$6.58M 10-K · filed 2014-03-17 | ||||||||||||
| 2013-09-30 | -$1.32M 10-Q · filed 2014-11-06 | -$4.21M derived: sum of 2 quarters · filed 2014-11-06 | -$2.93M 10-Q · filed 2014-11-06 | -$7.83M derived: sum of 4 quarters · filed 2015-03-12 | -$8.43M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | -$2.90M 10-Q · filed 2014-08-07 | -$1.62M 10-Q · filed 2014-08-07 | -$6.51M derived: sum of 3 quarters · filed 2015-03-12 | -$6.12M derived: sum of 4 quarters · filed 2015-03-12 | -$7.11M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $1.28M 10-Q · filed 2014-05-12 | -$3.62M derived: sum of 2 quarters · filed 2015-03-12 | -$3.23M derived: sum of 3 quarters · filed 2015-03-12 | -$5.41M derived: sum of 4 quarters · filed 2015-03-12 | -$4.22M 10-Q · filed 2013-05-14 | ||||||||||||
| 2012-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$4.51M derived: sum of 2 quarters · filed 2015-03-12 | -$6.69M derived: sum of 3 quarters · filed 2015-03-12 | -$6.72M 10-K · filed 2015-03-12 | -$5.49M 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | $388.75K 10-Q · filed 2013-11-14 | -$1.79M derived: sum of 2 quarters · filed 2013-11-14 | -$1.82M 10-Q · filed 2013-11-14 | -$2.19M derived: sum of 4 quarters · filed 2014-03-17 | -$598.56K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | -$2.18M 10-Q · filed 2013-08-14 | -$2.21M 10-Q · filed 2013-08-14 | -$2.58M derived: sum of 3 quarters · filed 2014-03-17 | -$2.47M derived: sum of 4 quarters · filed 2014-03-17 | -$987.31K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | -$32.42K 10-Q · filed 2013-05-14 | -$402.54K derived: sum of 2 quarters · filed 2014-03-17 | -$284.50K derived: sum of 3 quarters · filed 2014-03-17 | -$58.08K derived: sum of 4 quarters · filed 2014-03-17 | $1.19M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$370.12K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$252.08K derived: sum of 2 quarters · filed 2014-03-17 | -$25.66K derived: sum of 3 quarters · filed 2014-03-17 | $170.67K 10-K · filed 2014-03-17 | |||||||||||||
| 2011-09-30 | $118.04K 10-Q · filed 2012-11-14 | $344.46K derived: sum of 2 quarters · filed 2012-11-14 | $540.79K 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-06-30 | $226.42K 10-Q · filed 2012-08-14 | $422.75K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | $196.33K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |